Best practices for bioinformatic characterization of neoantigens for clinical utility

Neoantigens are newly formed peptides created from somatic mutations that are capable of inducing tumor-specific T cell recognition. Recently, researchers and clinicians have leveraged next generation sequencing technologies to identify neoantigens and to create personalized immunotherapies for canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Richters, Megan M., Xia, Huiming, Campbell, Katie M., Gillanders, William E., Griffith, Obi L., Griffith, Malachi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714459/
https://www.ncbi.nlm.nih.gov/pubmed/31462330
http://dx.doi.org/10.1186/s13073-019-0666-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714459/
https://www.ncbi.nlm.nih.gov/pubmed/31462330
http://dx.doi.org/10.1186/s13073-019-0666-2

Ejemplares similares